Lipoic acid in secondary progressive MS: A randomized controlled pilot trial

OBJECTIVE: To determine whether lipoic acid (LA), an endogenously produced antioxidant, slowed the whole-brain atrophy rate and was safe in secondary progressive MS (SPMS). METHODS: Patients with SPMS aged 40–70 years enrolled in a single center, 2-year, double-blind, randomized trial of daily oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Spain, Rebecca, Powers, Katherine, Murchison, Charles, Heriza, Elizabeth, Winges, Kimberly, Yadav, Vijayshree, Cameron, Michelle, Kim, Ed, Horak, Fay, Simon, Jack, Bourdette, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489387/
https://www.ncbi.nlm.nih.gov/pubmed/28680916
http://dx.doi.org/10.1212/NXI.0000000000000374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489387/
https://www.ncbi.nlm.nih.gov/pubmed/28680916
http://dx.doi.org/10.1212/NXI.0000000000000374

Ejemplares similares